Bone marrow biopsy in the initial staging of Ewing sarcoma: Experience from a single institution

Marilena Cesari, Alberto Righi, Marco Colangeli, Marco Gambarotti, Paolo Spinnato, Andrea Ferraro, Alessandra Longhi, Massimo Eraldo Abate, Emanuela Palmerini, Anna Paioli, Cristina Ferrari, Davide Maria Donati, Piero Picci, Stefano Ferrari

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Ewing sarcoma (ES) is the second most common bone tumor in adolescents and children. Staging workup for ES includes imaging and bone marrow biopsy (BMB). The effective role of BMB is now under discussion.

PROCEDURE: A monoinstitutional retrospective analysis reviewed clinical charts, imaging, and histology of patients with diagnosis of ES treated at the Rizzoli Institute between 1998 and 2017.

RESULTS: The cohort included 504 cases of ES of bone; 137 (27%) had metastases at diagnosis, while the remaining 367 had localized disease. Twelve patients had a positive BMB (2.4%). Eleven had distant metastases detected at initial workup staging with imaging assessment: six patients presented with bone metastases, five with both bone and lung metastases. Only one patient with ES of the foot (second metatarsus) was found to have bone marrow involvement with negative imaging evaluation (0.3%).

CONCLUSIONS: On the basis of our data, we suggest reconsidering the effective role of BMB in initial staging workup for patients with ES with no signs of metastases by modern imaging techniques. In metastatic disease, the assessment of the bone marrow status may remain useful to identify a group of patients at very high risk who could benefit from different treatment strategies.

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalPediatric Blood and Cancer
Volume66
Issue number6
Early online dateFeb 5 2019
DOIs
Publication statusPublished - Jun 2019

    Fingerprint

Keywords

  • Ewing sarcoma
  • bone marrow biopsy
  • staging

Cite this